A phase Ii study of 1- (2-chloroethyl) -3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancer
Moertel, C.G.; Schutt, A.J.; Reitemeier, R.J.; Hahn, R.G.
Cancer Research 32(6): 1278-1279
1972
ISSN/ISBN: 0008-5472 PMID: 4113144 Document Number: 51571
Document emailed within 1 workday
Related Documents
Habraken, Y.; Carter, C.A.; Kirk, M.C.; Ludlum, D.B. 1991: Release of 7-alkylguanines from N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea-modified DNA by 3-methyladenine DNA glycosylase Ii Cancer Research 51(2): 499-503Siemann, D.W.; Maddison, K.; Wolf, K.; Hill, S.A.; Keng, P.C. 1985: In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice Cancer Research 45(1): 198-202
Tew, K.D.; Sudhakar, S.; Schein, P.S.; Smulson, M.E. 1978: Binding of chlorozotocin and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea to chromatin and nucleosomal fractions of Hela cells Cancer Research 38(10): 3371-3378
Borel, A.G.; Abbott, F.S. 1993: Identification of carbamoylated thiol conjugates as metabolites of the antineoplastic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, in rats and humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(5): 889-901
Bethune, C.R.; Geyer, R.J.; Spence, A.M.; Ho, R.J. 2001: Lipid association improves the therapeutic index of lomustine [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea] to suppress 36B-10 tumor growth in rats Cancer Research 61(9): 3669-3674
Abele, R.; Alberto, P.; Germano, G.; Obrecht, J.P.; Wagenknecht, L. 1976: Simultaneous combination of adriamycin, bleomycin, cyclohexyl-chloroethyl nitrosourea with dimethyl-triazeno imidazole carboxamide in the treatment of Hodgkin's lymphoma Schweizerische Medizinische Wochenschrift 106(28): 961-963
Sakata, Y.; Shimada, Y.; Yoshino, M.; Kambe, M.; Futatsuki, K.; Nakao, I.; Ogawa, N.; Wakui, A.; Taguchi, T. 1994: A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(7): 1039-1046
Moertel, C.G.; Schutt, A.J.; Reitemeier, R.J.; Hahn, R.G. 1972: Phase Ii study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer Cancer ChemoTherapy Reports 56(1): 95-101
Sugihara, K.; Auther, C.; Mori, S.; Nishihira, T.; Matsumoto, T.; Kawachi, S.; Ishikawa, M.; Takahashi, M.; Nakajima, T.; Kosaki, G. 1990: Early phase Ii study of the combined use of AO-90 methionine-free amino acid solution and anticancer agents (5-FU and MMC) in patients with advanced and recurrent gastrointestinal cancer. AO-90 Study group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(12): 2405-2413
Zeller, W.J.; Berger, M.R.; Henne, T.; Weber, E. 1986: More than additive toxicity of the combination of 1-methyl-1-nitrosourea plus 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat Cancer Research 46(4 Part 1): 1714-1716
Durdyeva, E.D.; Kukushkina, G.V.; Gorbacheva, K.B. 1986: Relation between the changes in the structure and synthesis of DNA in the cells of mouse leukemia L1210 induced by 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea Biulleten' Eksperimental'noi Biologii i Meditsiny 101(2): 192-195
Wood, D.K. 1980: The draining malignant ulceration. Palliative management in advanced cancer JAMA 244(8): 820-822
Taguchi, T.; Wakui, A.; Nabeya, K.; Kurihara, M.; Isono, K.; Kakegawa, T.; Ota, K. 1992: A phase Ii clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(4): 483-488
Xu, Z.; Fu, Q.; Luo, X.; Lu, W. 2016: Does Surgical Bypass or Palliative Resections Offer the Better Palliative Treatment for Advanced Pancreatic Cancer? A Meta-Analysis American Surgeon 82(12): E346-E349
Doglietto, G.B.; Pacelli, F.; Caprino, P.; Alfieri, S.; Carriero, C.; Malerba, M.; Crucitti, F. 1999: Palliative surgery for far-advanced gastric cancer: a retrospective study on 305 consecutive patients American Surgeon 65(4): 352-355
Davis, R.B.; Van Echo, D.A.; Leone, L.A.; Henderson, E.S. 1986: Phase Ii trial of mitoxantrone in advanced primary liver cancer: a Cancer and Leukemia Group B Study Cancer Treatment Reports 70(9): 1125-1126
Veltman, J.C.; Anders, M.W. 1987: Cytotoxicity of N,N-bis(2-chloroethyl)-N-nitrosourea in hypoxic rat hepatocytes Cancer Research 47(19): 5087-5091
Lionetto, R.; Pronzato, P.; Conte, P.F.; Sertoli, M.R.; Amoroso, D.; Rosso, R. 1986: Idarubicin in advanced breast cancer: a phase II study Cancer Treatment Reports 70(12): 1439-1440
Rouësse, J.G.; Le Chevalier, T.; Caille, P.; Mondesir, J.M.; Sancho-Garnier, H.; May-Levin, F.; Spielmann, M.; De Jager, R.; Amiel, J.L. 1985: Phase Ii study of elliptinium in advanced breast cancer Cancer Treatment Reports 69(6): 707-708
Ogawa, M.; Kubo, K.; Tominaga, T.; Nomura, Y.; Ota, K.; Yoshida, M.; Taguchi, T.; Hoshino, A. 1986: Phase Ii study of mitoxantrone in advanced breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(5): 1980-1984